The risk corridor program, a controversial provision of the Affordable Care Act (ACA), received $5.5 billion in federal funding on Friday.
The “risk corridor” program, a controversial provision of the Affordable Care Act (ACA), received $5.5 billion in federal funding on Friday. The program protects insurance companies against the uncertainty of pricing quality health plans (QHPs) for the 2015 health insurance exchanges by establishing a risk-sharing agreement between them and the federal government. The Congressional Budget Office estimates that the program could generate as much as $16 billion in savings for insurers, and $8 billion in payments to the government.
Some policymakers remain wary of the agreement, and suggest that the administration repeal the provision. Officials, however, continue to endorse the risk corridor program as a way to mitigate any substantial premium increases insurers would incur next year due to the risk pool. Currently, insurers are unable to determine the exact ratio of young enrollees to those who are sick and elderly.
“The insurers who signed up for the exchange did so with the understanding that their risk was limited,” said Professor Timothy Jost, a healthcare expert at the Washington and Lee University School of Law. “So repealing those risk corridors is basically breaking a contract with the insurers that if they would come into this program, there’d be some limit to their risk exposure.”
The risk corridor program will raise the administrative cost ceiling to from 20% to 22%, and increase the risk corridor profit margin floor from 3% to 5%. Those insurers that exceed earning expectations would have to return any gains to the government.
“Because we believe that the effect of the transitional policy on the risk pool will be greater in states with higher enrollment in transitional plans, we will vary the state-specific percentage adjustment to the risk corridors formula based on the percentage enrollment in transitional plans within in a state,” said a statement from The Department of Health and Human Services.
Around the Web
HHS Outlines Policy Changes to Lift Insurers [The Hill]
$5.5 Billion for Obama’s Contested Risk Corridors [The Fiscal Times]
Obama Administration Again Delays Deadline for Cancelled Plans [Washington Examiner]
California Aims for Equity by Redefining Cancer Care
December 8th 2023Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Research Reveals the Role of Structural Racism in Lung Cancer Risk
December 7th 2023Spanning 22 studies, the analysis illuminated housing disparities, occupational hazards, unequal health care access, economic inequality, and discriminatory industry practices and how they collectively contribute to heightened lung cancer risks.
Read More
Refining Precision Prevention for Benign Breast Disease
December 7th 2023Many questions remain surrounding accurately classifying the risk of developing invasive breast cancer associated with the benign breast disease diagnoses of nonproliferative lesions and proliferative changes without atypia.
Read More